Literature DB >> 18854402

GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.

Anne P Beigneux1, Brandon S J Davies, André Bensadoun, Loren G Fong, Stephen G Young.   

Abstract

GPIHBP1, a small glycosylphosphatidylinositol-anchored glycoprotein, is required for the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 knockout mice exhibit chylomicronemia, even on a low-fat diet, with plasma triglyceride levels of 3,500-5,000 mg/dl. GPIHBP1 is expressed highly in heart, adipose tissue, and skeletal muscle, the same tissues that express high levels of lipoprotein lipase (LPL). In each of these tissues, GPIHBP1 is located in capillary endothelial cells. Chinese hamster ovary (CHO) cells transfected with a GPIHBP1 expression vector bind LPL and chylomicrons avidly. The expression of GPIHBP1 in mice is modulated by fasting and refeeding and is also regulated by peroxisome proliferator-activated receptor (PPAR)gamma agonists. Here, we review recent progress in understanding GPIHBP1 and discuss its role in lipolysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854402      PMCID: PMC2674691          DOI: 10.1194/jlr.R800030-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  Molecular evolution and phylogeny of elapid snake venom three-finger toxins.

Authors:  B G Fry; W Wüster; R M Kini; V Brusic; A Khan; D Venkataraman; A P Rooney
Journal:  J Mol Evol       Date:  2003-07       Impact factor: 2.395

2.  Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1.

Authors:  Ryoichi X Ioka; Man-Jong Kang; Shin Kamiyama; Dong-Ho Kim; Kenta Magoori; Akihisa Kamataki; Yuichiro Ito; Yumiko A Takei; Masako Sasaki; Takashi Suzuki; Hironobu Sasano; Sadao Takahashi; Juro Sakai; Takahiro Fujino; Tokuo T Yamamoto
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

3.  Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

4.  Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.

Authors:  P H Weinstock; C L Bisgaier; K Aalto-Setälä; H Radner; R Ramakrishnan; S Levak-Frank; A D Essenburg; R Zechner; J L Breslow
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

6.  PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity.

Authors:  Fiana Levitin; Mordechai Weiss; Yoonsoo Hahn; Omer Stern; Roger L Papke; Robert Matusik; Srinivas R Nandana; Ravit Ziv; Edward Pichinuk; Sharbel Salame; Tapan Bera; James Vincent; Byungkook Lee; Ira Pastan; Daniel H Wreschner
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

7.  Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase.

Authors:  Anne P Beigneux; Peter Gin; Brandon S J Davies; Michael M Weinstein; André Bensadoun; Robert O Ryan; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-03-13       Impact factor: 5.922

Review 8.  Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models.

Authors:  Murielle M Véniant; Anne P Beigneux; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

9.  CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera.

Authors:  David F Stroncek; Lorraine Caruccio; Maria Bettinotti
Journal:  J Transl Med       Date:  2004-03-29       Impact factor: 5.531

10.  The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma.

Authors:  Brandon S J Davies; Hironori Waki; Anne P Beigneux; Emily Farber; Michael M Weinstein; Damien C Wilpitz; Li-Jung Tai; Ronald M Evans; Loren G Fong; Peter Tontonoz; Stephen G Young
Journal:  Mol Endocrinol       Date:  2008-09-11
View more
  29 in total

1.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

2.  Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.

Authors:  Nosratola D Vaziri; Jun Yuan; Zhenmin Ni; Susanne B Nicholas; Keith C Norris
Journal:  Clin Exp Nephrol       Date:  2011-10-19       Impact factor: 2.801

Review 3.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

4.  Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Qiaoling Yao; Shannon Bevans-Fonti; James Poole; Luciano F Drager; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.310

Review 5.  Chylomicronaemia--current diagnosis and future therapies.

Authors:  Amanda J Brahm; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

Review 6.  GPIHBP1, an endothelial cell transporter for lipoprotein lipase.

Authors:  Stephen G Young; Brandon S J Davies; Constance V Voss; Peter Gin; Michael M Weinstein; Peter Tontonoz; Karen Reue; André Bensadoun; Loren G Fong; Anne P Beigneux
Journal:  J Lipid Res       Date:  2011-08-15       Impact factor: 5.922

Review 7.  Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.

Authors:  Vineeta Sharma; Trudy M Forte; Robert O Ryan
Journal:  Curr Opin Lipidol       Date:  2013-04       Impact factor: 4.776

8.  Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence.

Authors:  Aurélie Villaret; Jean Galitzky; Pauline Decaunes; David Estève; Marie-Adeline Marques; Coralie Sengenès; Patrick Chiotasso; Tamara Tchkonia; Max Lafontan; James L Kirkland; Anne Bouloumié
Journal:  Diabetes       Date:  2010-08-16       Impact factor: 9.461

Review 9.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

10.  Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.

Authors:  Angelo B Cefalù; Davide Noto; Maria Luisa Arpi; Fen Yin; Rossella Spina; Hannele Hilden; Carlo M Barbagallo; Antonio Carroccio; Patrizia Tarugi; Sebastiano Squatrito; Riccardo Vigneri; Marja-Riitta Taskinen; Miklós Péterfy; Maurizio R Averna
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.